Vaccine web pages

World Bank and Vaccines

Overview of World's Bank involvement in Vaccines, about funding mechanisms, and useful links.

The international vaccine institute

This is an institute in Seoul, with the mission "to accelerate the introduction of vaccines into developing country public health programs by undertaking research and providing research-based technical assistance that effectively address issues of vaccine development, disease burden, safety and efficacy, delivery feasibility and effectiveness, and sustained supply". In addition, they have initiated "a cross-cutting project [adressing] vaccine financing, with a special focus on options for operating a Global Fund for Vaccines".

The International AIDS Vaccine Initiative

An NGO with the mission to ensure the development of safe, effective, accessible preventive HIV vaccines for use throughout the world

"All participants in IAVI''s vaccine development partnerships agree to an intellectual property agreement that allows both for free-market recouping of investments and for faster and wider distribution of vaccines. Under the IAVI intellectual property agreements, product developers can charge market prices in industrialized countries. When patents are filed by an academic center or its partners, however, IAVI is free to choose from one of several measures to ensure global accessibility: a non-exclusive, royalty-free license for production in the developing world; an exclusive license with certain restrictions; 25% of all net royalties or sales from intellectual property rights; or an agreement from the manufacturer to sell vaccines at a small percentage above cost in developing nations."

Global Alliance for Vaccines and Immunizations

"The Global Alliance for Vaccines and Immunization is a partnership dedicated to ensuring that all children, however poor, have equal access to these vaccines. The Alliance also works to spur the development of new vaccines against major killers that primarily affect the world's poorest people. It is founded on the principle that immunization is a human right and a key step towards overcoming poverty."

European Malaria Vaccine Initiative

The aim of EMVI is to provide a mechanism through which the development of experimental malaria vaccines can be accelerated within Europe and in developing countries.

EMVI shall facilitate and contribute to the post validation phase of nationally and internationally funded malaria vaccine research and development, and will provide a mechanism to see candidate molecules through to limited GMP production and clinical trials in close collaboration with AMVTN. EMVI will provide a forum for scientists and policy makers engaged in malaria vaccine research and development.

WHO's vaccine unit

See especially the access to technologies link: Goal is to "reduce financial and technical barriers to the introduction of new and existing vaccines and immunization-related technologies, by

• Coordinating global demand and capacity
• Ensuring availability of appropriate supply sources, whether from local production, direct procurement or agency procurement
• Developing and promoting potential financing mechanisms Providing support for technology transfer
• Ensuring capacity to oversee and regulate these products by strengthening national regulatory authorities (including Global Training Network) and national supervision"

Malaria Vaccine Initiative

The MVI was created through a grant of the William H. Gates Foundation to PATH (Program for Appropriate Technology in Health). The objective of the MVI will be to significantly accelerate the clinical development of promising malaria vaccine candidates. The MVI is expected to lead to field trials of one or more vaccine candidates; coordinate its efforts with malaria vaccine programs at various organizations and agencies; and identify gaps in current research efforts and apply resources to advance promising malaria vaccine candidates."